Intelligent Medical Device Management through Synergistic Combinations
Legal Citation
Summary of the Inventive Concept
The inventive concept integrates medical device management with emerging technologies like blockchain, AI, IoT, and augmented reality to create a more powerful, efficient, and secure system for fluid delivery and patient care.
Background and Problem Solved
Conventional infusion pumps and medical device management systems have limitations in terms of data security, error prevention, and caregiver efficiency. The original patent addresses some of these issues through associations, but the new inventive concept takes a significant leap forward by incorporating advanced technologies to overcome these limitations.
Detailed Description of the Inventive Concept
The new system combines the original patent's association-based approach with blockchain technology to track and record fluid delivery events in real-time, ensuring data integrity and security. It also incorporates machine learning algorithms to predict and prevent potential errors in fluid delivery. Additionally, the system integrates AI-powered natural language processing to generate personalized treatment plans, IoT technology to optimize device performance, and augmented reality to enhance caregiver visualization and tracking. These synergistic combinations enable a more efficient, secure, and patient-centric medical device management system.
Novelty and Inventive Step
The new claims introduce novel combinations of emerging technologies with medical device management, providing a non-obvious and innovative solution that significantly improves upon the original patent. The inventive step lies in the integration of these distinct technologies to create a more powerful and efficient system.
Alternative Embodiments and Variations
Alternative embodiments could include using different blockchain architectures, integrating additional AI modules for predictive analytics, or incorporating other emerging technologies like 5G or edge computing. Variations could also involve applying the inventive concept to different medical devices or patient care scenarios.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in the healthcare industry, particularly in hospitals, clinics, and pharmacies. It could also be applied to other industries, such as medical research and pharmaceuticals, where efficient and secure medical device management is crucial. The target market includes healthcare providers, medical device manufacturers, and technology companies looking to innovate in the healthcare space.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61M5/142 |
| G | G16 | G16H20/17 |
| G | G16 | G16H40/20 |
| G | G16 | G16H40/67 |
| A | A61 | A61M2205/3561 |
| A | A61 | A61M2205/6009 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical device management systems, specifically infusion pump networks, patient care technology, and interconnected medical device communication with expertise in network protocols, medical informatics, and device integration
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or medical device systems specialist with advanced knowledge of networked medical technologies, wireless communication protocols, data management systems, and emerging healthcare informatics techniques
Obviousness Rationale
A PHOSITA would recognize that integrating emerging technologies like blockchain, AI, and IoT into medical device management represents predictable technological evolution. The source patent's foundational work on device associations provides a clear framework for expanding functionality through known technological augmentation techniques. The disclosed variations represent logical extensions of existing medical device communication paradigms using well-understood technological integration strategies.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,755 |
|---|---|
| Title | Medical device management using associations |
| Assignee(s) | Fresenius Kabi USA, LLC |